Rizatriptan NDC 33342-087

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-087Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0087Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-087-07	33342008707	30 TABLET, FILM COATED in 1 CONTAINER (33342-087-07)Marketed from Mar 11, 2014
33342-087-12	33342008712	10 BLISTER PACK in 1 CARTON (33342-087-12) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Mar 11, 2014
33342-087-41	33342008741	3 BLISTER PACK in 1 CARTON (33342-087-41) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02)Marketed from Sep 3, 2018
33342-087-45	33342008745	2 BLISTER PACK in 1 CARTON (33342-087-45) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02)Marketed from Sep 3, 2018
33342-087-46	33342008746	200 TABLET, FILM COATED in 1 CONTAINER (33342-087-46)Marketed from Mar 11, 2014
33342-087-50	33342008750	4 BLISTER PACK in 1 CARTON (33342-087-50) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52)Marketed from Mar 11, 2014
33342-087-72	33342008772	6 BLISTER PACK in 1 CARTON (33342-087-72) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52)Marketed from Mar 11, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rizatriptan
Generic name (nonproprietary): rizatriptan
Active ingredients: Rizatriptan benzoate — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203147
Marketing start: Mar 11, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 33342-087_fe80232a-c329-47ed-8edd-7786e06f3c08SPL ID fe80232a-c329-47ed-8edd-7786e06f3c08SPL set ID 27bc2cfc-fefb-4b50-a0dc-6268c69b4902RxCUI 312840, 314209UNII WR978S7QHHUPC 0333342088468, 0333342087072, 0333342088079, 0333342087461
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342008707 followed by a unit qualifier and the quantity

Package 33342-0087-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2022.

Indications (excerpt from the label)

Ri zatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use • Rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks. • Rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ]. • Rizatriptan benzoate tablets are not i…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203147

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203147
Product	Strength	Form · route	Labeler	Product NDC
Rizatriptan	Rizatriptan benzoate 10 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-088
Rizatriptan Benzoate	Rizatriptan benzoate 10 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-447
Rizatriptan	Rizatriptan benzoate 10 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7747
Rizatriptan	Rizatriptan benzoate 10 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2980
Rizatriptan	Rizatriptan benzoate 10 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1352